Compare Fimperkasa Utama Tbk. (FIMP) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fimperkasa Utama Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Fimperkasa Utama Tbk. trades at Rp69 (market cap 27.6B), while Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 40.2× Fimperkasa Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| FIMP | RSCH | |
|---|---|---|
Market Cap | 27.6B | 1.11T |
Volume | — | 25.61M |
Lot | — | 256.07K |
Turnover | — | 10.76B |
Average Price | — | 420.16 |
Value | — | 10.76B |
Indicative Equilibrium Price | — | 430 |
Indicative Equilibrium Volume | — | 1.46K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fimperkasa Utama Tbk.
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Read more on FIMP →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
